Bonnie L. Bassler

Insider Reports History

Entity
Individual
Location
Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, New York
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Bonnie L. Bassler
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bonnie L. Bassler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc Director Class A Ordinary Shares 58,454 $1.57 M $26.80 Jun 28, 2024 Direct
REGENERON PHARMACEUTICALS, INC. Director Common Stock 1,382 $1.47 M $1,062.00 Jun 24, 2024 Direct
Cidara Therapeutics, Inc. Director Stock Option (right to buy) 42,500 Jun 22, 2023 Direct
Kaleido Biosciences, Inc. Director Stock Option (Right to Buy) 15,000 Jun 30, 2021 Direct
REGENERON PHARMACEUTICALS, INC. Director Non-Qualified Stock Option (right to buy) 3,028 Jun 24, 2024 Direct

Insider Reports Filed by Bonnie L. Bassler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RPRX Royalty Pharma plc Jun 28, 2024 1 37,493 4 Jun 28, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Jun 24, 2024 3 -522,094 4 Jun 25, 2024 Director
RPRX Royalty Pharma plc Jun 7, 2024 1 0 4 Jun 10, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Jun 5, 2024 3 -521,051 4 Jun 7, 2024 Director
RPRX Royalty Pharma plc Mar 28, 2024 1 37,483 4 Apr 2, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Feb 26, 2024 3 -501,580 4 Feb 26, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 30, 2024 3 -478,047 4 Jan 31, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 2, 2024 5 -440,299 4 Jan 4, 2024 Director
RPRX Royalty Pharma plc Dec 29, 2023 1 37,493 4 Dec 29, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Dec 13, 2023 3 -300,919 4 Dec 14, 2023 Director
RPRX Royalty Pharma plc Sep 29, 2023 1 37,475 4 Oct 3, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 21, 2023 3 -372,829 4 Aug 23, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 10, 2023 3 -338,709 4 Aug 11, 2023 Director
RPRX Royalty Pharma plc Jun 30, 2023 1 37,481 4 Jun 30, 2023 Director
RPRX Royalty Pharma plc Jun 23, 2023 1 0 4 Jun 26, 2023 Director
CDTX Cidara Therapeutics, Inc. Jun 22, 2023 1 0 4 Jun 23, 2023 Director
RPRX Royalty Pharma plc Mar 31, 2023 1 37,478 4 Mar 31, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Mar 24, 2023 3 -541,942 4 Mar 27, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Feb 3, 2023 3 -406,409 4 Feb 7, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 3, 2023 2 0 4 Jan 5, 2023 Director
RPRX Royalty Pharma plc Dec 30, 2022 1 37,495 4 Jan 3, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Dec 8, 2022 3 -86,775 4 Dec 12, 2022 Director
RPRX Royalty Pharma plc Sep 30, 2022 1 37,490 4 Sep 30, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Sep 8, 2022 9 -999,689 4 Sep 12, 2022 Director
RPRX Royalty Pharma plc Jun 30, 2022 1 37,493 4 Jun 30, 2022 Director
RPRX Royalty Pharma plc Jun 24, 2022 1 0 4 Jun 24, 2022 Director
CDTX Cidara Therapeutics, Inc. Jun 22, 2022 1 0 4 Jun 24, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Apr 7, 2022 3 -426,622 4 Apr 11, 2022 Director
RPRX Royalty Pharma plc Mar 31, 2022 1 37,471 4 Apr 1, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Mar 30, 2022 3 -395,622 4 Apr 1, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 3, 2022 2 0 4 Jan 5, 2022 Director
RPRX Royalty Pharma plc Dec 31, 2021 1 37,463 4 Jan 3, 2022 Director
RPRX Royalty Pharma plc Sep 30, 2021 1 37,499 4 Sep 30, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 16, 2021 3 -308,785 4 Aug 17, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 5, 2021 3 -532,477 4 Aug 6, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Jul 1, 2021 3 -468,319 4 Jul 2, 2021 Director
KLDO Kaleido Biosciences, Inc. Jun 30, 2021 1 0 4 Jul 1, 2021 Director
RPRX Royalty Pharma plc Jun 30, 2021 1 37,489 4 Jun 30, 2021 Director
RPRX Royalty Pharma plc Jun 25, 2021 1 0 4 Jun 29, 2021 Director
CDTX Cidara Therapeutics, Inc. Jun 23, 2021 1 0 4 Jun 24, 2021 Director